Cargando…

OA03.17. Pilot retrospective observational study to evaluate efficacy of customized ayurvedic therapy on Type 2 diabetes exhibiting secondary failure of oral hypoglycemic drugs

PURPOSE: The data was retrospectively collected through third part unbiased documentation conducted under RUDRA program at The Arya Vaidhya Chikitsalayam and Research Institute. Obtained data was evaluated to study the efficacy of customized ayurvedic therapy in on Type 2 diabetes exhibiting seconda...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Somit, Raveendran, KG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147511/
http://dx.doi.org/10.4103/0257-7941.123855
_version_ 1782332460303908864
author Kumar, Somit
Raveendran, KG
author_facet Kumar, Somit
Raveendran, KG
author_sort Kumar, Somit
collection PubMed
description PURPOSE: The data was retrospectively collected through third part unbiased documentation conducted under RUDRA program at The Arya Vaidhya Chikitsalayam and Research Institute. Obtained data was evaluated to study the efficacy of customized ayurvedic therapy in on Type 2 diabetes exhibiting secondary failure of oral hypoglycemic drugs. METHOD: Participants were retrospectively selected between Jan. to Dec. 2011 diagnosed with Type 2 Diabetes mellitus as primary or secondary morbidity during documentation. Out of 194 patients who visited our OPD with primary aim as management of their type 2 diabetes 27 cases found to have adequate baseline and endpoint data and satisfying the inclusion criterion were delineated, exhibiting secondary failure to oral hypoglycemic drug. At least 1 prescription claim for a sulfonylurea or a thiazolidinedione during study period along with metformin use include in the study. Secondary failure was measured for patients who initially achieved a Fasting and Post prandial blood glucose 126 mg/dl and 200 mg/dl but in due course of chronicity again rose above the said level, exhibiting secondary failure of oral hypoglycemic drugs RESULT: Participants (mean age, 50.034 (S.D. ±13.64) years; 55.6% female and 44.4 % males) who were known diabetic since 5.9185 (S.D. ±6.6) underwent a customized Ayurveda treatment with Allopathic oral hypoglycemic drugs as concomitant medication for average of 16.2 weeks. The mean baseline Fasting and Post prandial blood glucose was 163.26 (S.D. ± 50.57) and 230.23 (S.D.± 90.24244) and which was higher for the patients receiving a combination of metformin and sulfonylurea or thiazolidinedione. The mean Fasting blood glucose decreased to 131.49, and Post prandial 174.5 of patients as compared to baseline. This reduction in the Gycemic index was found to be statistically significant after administration of unpaired students ‘t’ test at significance level of <0.05. CONCLUSION: Customized Ayurveda treatment was able to ameliorate the Fasting and Post prandial blood sugar levels in patients with secondary failure to oral hypoglycemic drugs with type 2 diabetes.
format Online
Article
Text
id pubmed-4147511
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-41475112014-10-02 OA03.17. Pilot retrospective observational study to evaluate efficacy of customized ayurvedic therapy on Type 2 diabetes exhibiting secondary failure of oral hypoglycemic drugs Kumar, Somit Raveendran, KG Anc Sci Life Oral Presentation PURPOSE: The data was retrospectively collected through third part unbiased documentation conducted under RUDRA program at The Arya Vaidhya Chikitsalayam and Research Institute. Obtained data was evaluated to study the efficacy of customized ayurvedic therapy in on Type 2 diabetes exhibiting secondary failure of oral hypoglycemic drugs. METHOD: Participants were retrospectively selected between Jan. to Dec. 2011 diagnosed with Type 2 Diabetes mellitus as primary or secondary morbidity during documentation. Out of 194 patients who visited our OPD with primary aim as management of their type 2 diabetes 27 cases found to have adequate baseline and endpoint data and satisfying the inclusion criterion were delineated, exhibiting secondary failure to oral hypoglycemic drug. At least 1 prescription claim for a sulfonylurea or a thiazolidinedione during study period along with metformin use include in the study. Secondary failure was measured for patients who initially achieved a Fasting and Post prandial blood glucose 126 mg/dl and 200 mg/dl but in due course of chronicity again rose above the said level, exhibiting secondary failure of oral hypoglycemic drugs RESULT: Participants (mean age, 50.034 (S.D. ±13.64) years; 55.6% female and 44.4 % males) who were known diabetic since 5.9185 (S.D. ±6.6) underwent a customized Ayurveda treatment with Allopathic oral hypoglycemic drugs as concomitant medication for average of 16.2 weeks. The mean baseline Fasting and Post prandial blood glucose was 163.26 (S.D. ± 50.57) and 230.23 (S.D.± 90.24244) and which was higher for the patients receiving a combination of metformin and sulfonylurea or thiazolidinedione. The mean Fasting blood glucose decreased to 131.49, and Post prandial 174.5 of patients as compared to baseline. This reduction in the Gycemic index was found to be statistically significant after administration of unpaired students ‘t’ test at significance level of <0.05. CONCLUSION: Customized Ayurveda treatment was able to ameliorate the Fasting and Post prandial blood sugar levels in patients with secondary failure to oral hypoglycemic drugs with type 2 diabetes. Medknow Publications & Media Pvt Ltd 2013-01 /pmc/articles/PMC4147511/ http://dx.doi.org/10.4103/0257-7941.123855 Text en Copyright: © Ancient Science of Life http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Kumar, Somit
Raveendran, KG
OA03.17. Pilot retrospective observational study to evaluate efficacy of customized ayurvedic therapy on Type 2 diabetes exhibiting secondary failure of oral hypoglycemic drugs
title OA03.17. Pilot retrospective observational study to evaluate efficacy of customized ayurvedic therapy on Type 2 diabetes exhibiting secondary failure of oral hypoglycemic drugs
title_full OA03.17. Pilot retrospective observational study to evaluate efficacy of customized ayurvedic therapy on Type 2 diabetes exhibiting secondary failure of oral hypoglycemic drugs
title_fullStr OA03.17. Pilot retrospective observational study to evaluate efficacy of customized ayurvedic therapy on Type 2 diabetes exhibiting secondary failure of oral hypoglycemic drugs
title_full_unstemmed OA03.17. Pilot retrospective observational study to evaluate efficacy of customized ayurvedic therapy on Type 2 diabetes exhibiting secondary failure of oral hypoglycemic drugs
title_short OA03.17. Pilot retrospective observational study to evaluate efficacy of customized ayurvedic therapy on Type 2 diabetes exhibiting secondary failure of oral hypoglycemic drugs
title_sort oa03.17. pilot retrospective observational study to evaluate efficacy of customized ayurvedic therapy on type 2 diabetes exhibiting secondary failure of oral hypoglycemic drugs
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147511/
http://dx.doi.org/10.4103/0257-7941.123855
work_keys_str_mv AT kumarsomit oa0317pilotretrospectiveobservationalstudytoevaluateefficacyofcustomizedayurvedictherapyontype2diabetesexhibitingsecondaryfailureoforalhypoglycemicdrugs
AT raveendrankg oa0317pilotretrospectiveobservationalstudytoevaluateefficacyofcustomizedayurvedictherapyontype2diabetesexhibitingsecondaryfailureoforalhypoglycemicdrugs
AT oa0317pilotretrospectiveobservationalstudytoevaluateefficacyofcustomizedayurvedictherapyontype2diabetesexhibitingsecondaryfailureoforalhypoglycemicdrugs